iBio, Inc. also files under IBIO, INC., IBIO US, IBPM.OB; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Carr Molly | Chief Medical Officer | Grant(A) | 430K | — | $0 |
| May 18, 2026 | Stoner Elizabeth | Director | Grant(A) | 60K | — | $0 |
| Mar 26, 2026 | Banjak Marc | Chief Legal Officer | Buy(P) | 13K | $1.64 | $21K |
| Mar 26, 2026 | Banjak Marc | Chief Legal Officer | Buy(P) | 1K | $1.76 | $3K |
| Mar 19, 2026 | Duran Felipe | Chief Financial Officer | Buy(P) | 25K | $2.02 | $50K |
| Mar 19, 2026 | Brenner Martin | See Remarks, Director | Buy(P) | 12K | $2.02 | $25K |
| Jan 28, 2026 | Banjak Marc | Chief Legal Officer | Grant(A) | 146K | — | $0 |
| Jan 28, 2026 | Duran Felipe | Chief Financial Officer | Grant(A) | 179K | — | $0 |
| Jan 28, 2026 | Brenner Martin | See Remarks, Director | Grant(A) | 479K | — | $0 |
| Nov 20, 2025 | Sender Gary | Director | Grant(A) | 14K | — | $0 |
| Nov 20, 2025 | Parada Antonio Bernardino Guimaraes | Director | Grant(A) | 14K | — | $0 |
| Nov 20, 2025 | Arkowitz David | Director | Grant(A) | 14K | — | $0 |
| Nov 20, 2025 | Kropotova Alexandra | Director | Grant(A) | 14K | — | $0 |
| Nov 20, 2025 | Clark William D | Director | Grant(A) | 14K | — | $0 |
| Nov 20, 2025 | Schimmelpennink Evert B. | Director | Grant(A) | 14K | — | $0 |
| Oct 20, 2025 | Duran Felipe | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Oct 20, 2025 | Banjak Marc | Chief Legal Officer | Grant(A) | 55K | — | $0 |
| Oct 20, 2025 | Brenner Martin | See Remarks, Director | Grant(A) | 180K | — | $0 |
| Feb 21, 2025 | Banjak Marc | Chief Legal Officer | Grant(A) | 71K | — | $0 |
| Feb 21, 2025 | Brenner Martin | See Remarks, Director | Grant(A) | 231K | — | $0 |
| Feb 21, 2025 | Duran Felipe | Chief Financial Officer | Grant(A) | 85K | — | $0 |
| Jan 10, 2025 | Sender Gary | Director | Buy(P) | 9K | $2.72 | $25K |
| Jan 10, 2025 | Brenner Martin | See Remarks, Director | Buy(P) | 9K | $2.72 | $25K |
| Jan 10, 2025 | Duran Felipe | Chief Financial Officer | Buy(P) | 9K | $2.72 | $25K |
| Jan 10, 2025 | Banjak Marc | Chief Legal Officer | Buy(P) | 9K | $2.72 | $25K |
| Jan 10, 2025 | Arkowitz David | Director | Buy(P) | 18K | $2.72 | $50K |
| Jan 10, 2025 | Parada Antonio Bernardino Guimaraes | Director | Buy(P) | 184K | $2.72 | $500K |
| Jan 10, 2025 | Clark William D | Director | Buy(P) | 2K | $2.72 | $5K |
| Nov 21, 2024 | Sender Gary | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Schimmelpennink Evert B. | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Kropotova Alexandra | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Clark William D | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Parada Antonio Bernardino Guimaraes | Director | Grant(A) | 13K | — | $0 |
| Nov 21, 2024 | Arkowitz David | Director | Grant(A) | 13K | — | $0 |
| May 9, 2024 | Brenner Martin | See Remarks | Grant(A) | 147K | — | $0 |
| May 9, 2024 | Duran Felipe | Chief Financial Officer | Grant(A) | 90K | — | $0 |
| May 9, 2024 | Brenner Martin | See Remarks | Grant(A) | 110K | — | $0 |
| Apr 25, 2024 | Duran Felipe | Chief Financial Officer | Grant(A) | 36K | — | $0 |
| Nov 1, 2023 | Brenner Martin | See Remarks | Sell(S) | 5K | $0.27 | $1K |
| Oct 3, 2023 | Brenner Martin | See Remarks | Sell(S) | 5K | $0.30 | $2K |
| Oct 2, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $0.31 | $1K |
| Aug 28, 2023 | Brenner Martin | See Remarks | Sell(S) | 5K | $0.31 | $2K |
| Aug 23, 2023 | Duran Felipe | Chief Financial Officer | Grant(A) | 60K | — | $0 |
| Aug 23, 2023 | Brenner Martin | See Remarks | Grant(A) | 120K | — | $0 |
| Jul 27, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $0.51 | $2K |
| Jul 27, 2023 | Brenner Martin | See Remarks | Sell(S) | 35 | $0.51 | $18 |
| Jul 12, 2023 | Brenner Martin | See Remarks | Sell(S) | 47K | $0.59 | $28K |
| Jun 26, 2023 | Brenner Martin | See Remarks | Grant(A) | 76K | — | $0 |
| Jun 22, 2023 | Brenner Martin | See Remarks | Disposed to issuer(D) | 76K | — | $0 |
| Jun 21, 2023 | Brenner Martin | See Remarks | Sell(S) | 100 | $0.68 | $68 |
| Jun 21, 2023 | Brenner Martin | See Remarks | Sell(S) | 225 | $0.69 | $155 |
| Jun 21, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $0.68 | $3K |
| May 22, 2023 | Brenner Martin | See Remarks | Sell(S) | 24 | $0.95 | $23 |
| May 22, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $0.94 | $4K |
| Apr 24, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $1.20 | $5K |
| Mar 31, 2023 | Duran Felipe | Chief Financial Officer | Grant(A) | 38K | — | $0 |
| Mar 31, 2023 | Brenner Martin | See Remarks | Grant(A) | 50K | — | $0 |
| Mar 23, 2023 | Brenner Martin | See Remarks | Sell(S) | 5K | $2.13 | $11K |
| Feb 21, 2023 | Brenner Martin | See Remarks | Sell(S) | 4K | $1.77 | $7K |
| Jan 20, 2023 | Brenner Martin | Interim CEO and CSO | Grant(A) | 130K | — | $0 |
| Nov 11, 2022 | Brenner Martin | Chief Scientific Officer | Grant(A) | 95K | — | $0 |
| Nov 11, 2022 | Lutz Robert Matthew | See Remarks | Grant(A) | 100K | — | $0 |
| Sep 8, 2022 | Isett Thomas Francis 3rd | CEO and Executive Chairman, Director | Grant(A) | 2.0M | — | $0 |
| Aug 29, 2022 | Lutz Robert Matthew | See Remark | Grant(A) | 400K | — | $0 |
| Aug 29, 2022 | Brenner Martin | Chief Scientific Officer | Grant(A) | 700K | — | $0 |
| Mar 10, 2022 | Lutz Robert Matthew | See Remarks | Sell(S) | 25K | $0.35 | $9K |
| Dec 9, 2021 | Chang Glenn | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | McKey John D JR | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | Clark William D | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | Schimmelpennink Evert B. | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | Kropotova Alexandra | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | Armstrong Linda Washington | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | Sender Gary | Director | Grant(A) | 109K | — | $0 |
| Dec 9, 2021 | General Hill (Ret) James T. | Director | Grant(A) | 109K | — | $0 |
| Dec 7, 2021 | Maddux Randy Joe | Chief Operating Officer | Sell(S) | 37K | $0.68 | $25K |
| Sep 23, 2021 | Isett Thomas Francis 3rd | CEO and Executive Chairman, Director | Grant(A) | 2.0M | — | $0 |
| Aug 23, 2021 | Clark William D | Director | Grant(A) | 100K | — | $0 |
| Aug 23, 2021 | Isett Thomas Francis 3rd | CEO and Executive Chairman, Director | Grant(A) | 2.0M | — | $0 |
| Aug 23, 2021 | Lutz Robert Matthew | See Remarks | Grant(A) | 500K | — | $0 |
| Aug 23, 2021 | Maddux Randy Joe | Chief Operating Officer | Grant(A) | 500K | — | $0 |
| Aug 23, 2021 | Brenner Martin | Chief Scientific Officer | Grant(A) | 700K | — | $0 |
| Jun 7, 2021 | Schimmelpennink Evert B. | Director | Grant(A) | 100K | — | $0 |
| Apr 30, 2021 | Isett Thomas Francis 3rd | CEO and Executive Chairman, Director | Grant(A) | 3.0M | $1.37 | $4.1M |
| Mar 4, 2021 | Lutz Robert Matthew | See Remarks | Grant(A) | 350K | — | $0 |
| Mar 4, 2021 | Lutz Robert Matthew | See Remarks | Grant(A) | 232K | — | $0 |
| Jan 18, 2021 | Brenner Martin | Chief Scientific Officer | Grant(A) | 500K | — | $0 |
| Dec 1, 2020 | Maddux Randy Joe | Chief Operating Officer | Grant(A) | 465K | — | $0 |
| Dec 1, 2020 | Maddux Randy Joe | Chief Operating Officer | Grant(A) | 309K | — | $0 |
| Oct 14, 2020 | Kropotova Alexandra | Director | Grant(A) | 100K | — | $0 |
| Oct 14, 2020 | Sender Gary | Director | Grant(A) | 100K | — | $0 |
| Oct 14, 2020 | Armstrong Linda Washington | Director | Grant(A) | 100K | — | $0 |
| Aug 11, 2020 | Portfolio Services Ltd. | 10% Owner | Sell(S) | 15.9M | $2.92 | $46.3M |
| Aug 10, 2020 | Portfolio Services Ltd. | 10% Owner | Sell(S) | 7.3M | $3.91 | $28.4M |
| Aug 7, 2020 | Portfolio Services Ltd. | 10% Owner | Conversion(C) | 6K | — | — |
| Aug 7, 2020 | Portfolio Services Ltd. | 10% Owner | Sell(S) | 1.4M | $3.83 | $5.2M |
| Aug 7, 2020 | Portfolio Services Ltd. | 10% Owner | Conversion(C) | 28.9M | $0.20 | $5.8M |
| Aug 6, 2020 | Eastern Capital LTD | 10% Owner | Sell(S) | 2.8M | $4.18 | $11.6M |
| Aug 5, 2020 | Eastern Capital LTD | 10% Owner | Sell(S) | 900K | $4.46 | $4.0M |
| Aug 4, 2020 | Eastern Capital LTD | 10% Owner | Sell(S) | 600K | $4.39 | $2.6M |
| Jun 12, 2020 | Kay Robert | Director | Grant(A) | 400K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: iBio, Inc., SEC CIK 0001420720. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under IBIO and shows every filing by that issuer (also filed as IBIO, INC., IBIO US, IBPM.OB).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for IBIO